Corbus Pharmaceuticals Holdings Inc. Stock Advances 4.5%, Outperforms Market

Dow Jones11-27

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. advanced 4.5% to $11.88 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.8% to 23,214.69 and the Dow Jones Industrial Average rising 0.7% to 47,427.12.

The stock's rise snapped a two-day losing streak.

Corbus Pharmaceuticals Holdings Inc. closed 42.2% short of its 52-week high of $20.56, which the company reached on October 20th.

The stock demonstrated a mixed performance when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 6.0% to $5.30, Fortress Biotech Inc. rose 2.6% to $2.76, and Viking Therapeutics Inc. rose 2.28% to $36.27.

Trading volume totaled 129,042, compared to the 50-day average of 412,772.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 26, 2025 16:34 ET (21:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment